[TLX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -20.02%
YoY- -99.81%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
Revenue 3,606 1,607 1,667 1,818 195 0 49 318.51%
PBT -35,157 -25,096 -25,690 -17,125 -10,524 -5,190 -4,806 94.00%
Tax -8,571 -6,795 -8,192 -6,756 1,884 -5,190 -471 162.79%
NP -26,586 -18,301 -17,497 -10,370 -8,640 -5,190 -4,806 76.76%
Tax Rate - - - - - - - -
Total Cost 30,192 19,908 19,165 12,187 8,835 5,190 4,854 83.80%
Ratio Analysis
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
NP Margin -737.27 -1,138.83 -1,049.33 -570.54 -4,430.77 0.00 -9,850.62 -57.82%
Per Share
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
EPS -0.10 -0.07 -0.07 -0.05 -0.04 -0.03 -0.02 70.91%
EPS Diluted -0.10 -0.07 -0.07 -0.05 -0.04 -0.03 -0.02 70.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.